These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 3275857)

  • 1. Quantification of the relative impairment in actions of insulin on hepatic glucose production and peripheral glucose uptake in non-insulin-dependent diabetes mellitus.
    Campbell PJ; Mandarino LJ; Gerich JE
    Metabolism; 1988 Jan; 37(1):15-21. PubMed ID: 3275857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of hyperglycemia on insulin's in vivo effects in type II diabetes.
    Revers RR; Fink R; Griffin J; Olefsky JM; Kolterman OG
    J Clin Invest; 1984 Mar; 73(3):664-72. PubMed ID: 6368585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged sulfonylurea administration decreases insulin resistance and increases insulin secretion in non-insulin-dependent diabetes mellitus: evidence for improved insulin action at a postreceptor site in hepatic as well as extrahepatic tissues.
    Mandarino LJ; Gerich JE
    Diabetes Care; 1984; 7 Suppl 1():89-99. PubMed ID: 6376034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM.
    Consoli A; Nurjhan N; Capani F; Gerich J
    Diabetes; 1989 May; 38(5):550-7. PubMed ID: 2653926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of hepatic glucose production and glucose uptake in the pathogenesis of fasting hyperglycemia in type 2 diabetes: normalization of glucose kinetics by short-term fasting.
    Féry F
    J Clin Endocrinol Metab; 1994 Mar; 78(3):536-42. PubMed ID: 8126123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of basal insulin supplementation on disposition of mixed meal in obese patients with NIDDM.
    McMahon M; Marsh HM; Rizza RA
    Diabetes; 1989 Mar; 38(3):291-303. PubMed ID: 2492963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of obesity on insulin action in NIDDM.
    Campbell PJ; Carlson MG
    Diabetes; 1993 Mar; 42(3):405-10. PubMed ID: 8432411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics.
    Baron AD; Schaeffer L; Shragg P; Kolterman OG
    Diabetes; 1987 Mar; 36(3):274-83. PubMed ID: 2879757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoxetine increases insulin action in obese nondiabetic and in obese non-insulin-dependent diabetic individuals.
    Potter van Loon BJ; Radder JK; Frölich M; Krans HM; Zwinderman AH; Meinders AE
    Int J Obes Relat Metab Disord; 1992 Feb; 16(2):79-85. PubMed ID: 1316330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exogenous insulin replacement in type 2 diabetes reverses excessive hepatic glucose release, but not excessive renal glucose release and impaired free fatty acid clearance.
    Woerle HJ; Popa E; Dostou J; Welle S; Gerich J; Meyer C
    Metabolism; 2002 Nov; 51(11):1494-500. PubMed ID: 12404204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-sensitive and insulin-resistant variants in NIDDM.
    Banerji MA; Lebovitz HE
    Diabetes; 1989 Jun; 38(6):784-92. PubMed ID: 2656347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of improvement in glucose metabolism after chronic glyburide therapy.
    Simonson DC; Ferrannini E; Bevilacqua S; Smith D; Barrett E; Carlson R; DeFronzo RA
    Diabetes; 1984 Sep; 33(9):838-45. PubMed ID: 6432610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased epinephrine and skeletal muscle responses to hypoglycemia in non-insulin-dependent diabetes mellitus.
    Shamoon H; Friedman S; Canton C; Zacharowicz L; Hu M; Rossetti L
    J Clin Invest; 1994 Jun; 93(6):2562-71. PubMed ID: 8200993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo hepatic and peripheral insulin sensitivity in rats with non-insulin-dependent diabetes induced by streptozocin. Assessment with the insulin-glucose clamp technique.
    Kergoat M; Portha B
    Diabetes; 1985 Nov; 34(11):1120-6. PubMed ID: 3899811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycemic control determines hepatic and peripheral glucose effectiveness in type 2 diabetic subjects.
    Hawkins M; Gabriely I; Wozniak R; Reddy K; Rossetti L; Shamoon H
    Diabetes; 2002 Jul; 51(7):2179-89. PubMed ID: 12086948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic and extrahepatic responses to insulin in NIDDM and nondiabetic humans. Assessment in absence of artifact introduced by tritiated nonglucose contaminants.
    Butler PC; Kryshak EJ; Schwenk WF; Haymond MW; Rizza RA
    Diabetes; 1990 Feb; 39(2):217-25. PubMed ID: 2227130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different sensitivity of glucose and amino acid metabolism to insulin in NIDDM.
    Luzi L; Petrides AS; De Fronzo RA
    Diabetes; 1993 Dec; 42(12):1868-77. PubMed ID: 8243833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake.
    DeFronzo RA; Ferrannini E; Simonson DC
    Metabolism; 1989 Apr; 38(4):387-95. PubMed ID: 2657323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of glyburide on in vivo insulin-mediated glucose disposal.
    Simonson DC
    Am J Med; 1990 Aug; 89(2A):44S-50S; discussion 51S-53S. PubMed ID: 2117389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-induced decline of plasma amino acid concentrations in obese subjects with and without non-insulin-dependent diabetes.
    Pijl H; Potter van Loon BJ; Toornvliet AC; Radder JK; Onkenhout W; Frölich M; Meinders AE
    Metabolism; 1994 May; 43(5):640-6. PubMed ID: 8177054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.